Literature DB >> 7696959

The biology and action of colony stimulating factor-1.

E R Stanley1, K L Berg, D B Einstein, P S Lee, Y G Yeung.   

Abstract

Colony stimulating factor 1 (CSF-1) is a growth factor for mononuclear phagocytic cells. Through alternative mRNA splicing and differential post-translational proteolytic processing, CSF-1 can either be secreted into the circulation as a glycoprotein or chondroitin sulfate-containing proteoglycan or expressed as a membrane-spanning glycoprotein on the surface of synthesizing cells. The discovery that the osteopetrotic (op/op) mutant mouse possesses an inactivating mutation in the CSF-1 gene has greatly contributed to our understanding of CSF-1 biology. CSF-1 directly regulates some non-mononuclear phagocytic cells that express the CSF-1 receptor tyrosine kinase, but is not required for their development. However, it directly regulates the development and maintenance of tissue macrophage subpopulations that appear to have important trophic and/or scavenger roles in tissue morphogenesis and function. Depending on the tissue, this regulation may be local (via the cell-surface form) localized (via the sequestered proteoglycan form) or humoral. It appears that the CSF-1 dependent tissue macrophage subpopulations, via their effects on other cell types, can significantly affect functions in tissues as diverse as testis, brain and skin, and their absence in op/op mice may explain the pleiotropy of the op/op phenotype. To investigate post-CSF-1 receptor signaling in the macrophage, procedures have been developed for the purification and sequence determination of the proteins that are rapidly phosphorylated on tyrosine in response to CSF-1. Several have been identified and the behavior of one of them, protein tyrosine phosphatase 1C (PTP1C), is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7696959

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  17 in total

1.  CSF-1 and TPA stimulate independent pathways leading to lysosomal degradation or regulated intramembrane proteolysis of the CSF-1 receptor.

Authors:  Gary Glenn; Peter van der Geer
Journal:  FEBS Lett       Date:  2007-10-29       Impact factor: 4.124

2.  Induced expression and association of the Mona/Gads adapter and Gab3 scaffolding protein during monocyte/macrophage differentiation.

Authors:  Caroline Bourgin; Roland P Bourette; Sylvie Arnaud; Yan Liu; Larry R Rohrschneider; Guy Mouchiroud
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

3.  Extracellular matrix from porcine small intestinal submucosa (SIS) as immune adjuvants.

Authors:  Youssef Aachoui; Swapan K Ghosh
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

Review 4.  IL-34 and CSF-1: similarities and differences.

Authors:  Yuko Nakamichi; Nobuyuki Udagawa; Naoyuki Takahashi
Journal:  J Bone Miner Metab       Date:  2013-06-06       Impact factor: 2.626

5.  Endocan, a novel inflammatory marker, is upregulated in human chondrocytes stimulated with IL-1 beta.

Authors:  Michele Scuruchi; Angela D'Ascola; Angela Avenoso; Giuseppe Mandraffino; Salvatore Campo; Giuseppe M Campo
Journal:  Mol Cell Biochem       Date:  2021-01-05       Impact factor: 3.396

6.  T-cell protein tyrosine phosphatase (Tcptp) is a negative regulator of colony-stimulating factor 1 signaling and macrophage differentiation.

Authors:  Paul D Simoncic; Annie Bourdeau; Ailsa Lee-Loy; Larry R Rohrschneider; Michel L Tremblay; E Richard Stanley; C Jane McGlade
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

7.  Spleen serves as a reservoir of osteoclast precursors through vitamin D-induced IL-34 expression in osteopetrotic op/op mice.

Authors:  Yuko Nakamichi; Toshihide Mizoguchi; Atsushi Arai; Yasuhiro Kobayashi; Masahiro Sato; Josef M Penninger; Hisataka Yasuda; Shigeaki Kato; Hector F DeLuca; Tatsuo Suda; Nobuyuki Udagawa; Naoyuki Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-05       Impact factor: 11.205

8.  TRAP-positive osteoclast precursors mediate ROS/NO-dependent bactericidal activity via TLR4.

Authors:  Kazuaki Nishimura; Satoru Shindo; Alexandru Movila; Rayyan Kayal; Albassam Abdullah; Irma Josefina Savitri; Atsushi Ikeda; Tsuguno Yamaguchi; Mohammed Howait; Ayman Al-Dharrab; Abdulghani Mira; Xiaozhe Han; Toshihisa Kawai
Journal:  Free Radic Biol Med       Date:  2016-06-22       Impact factor: 7.376

9.  Administration of high-dose macrophage colony-stimulating factor increases bone turnover and trabecular volume fraction.

Authors:  Shane A Lloyd; Yuyu Y Yuan; Steven J Simske; Stephanie E Riffle; Virginia L Ferguson; Ted A Bateman
Journal:  J Bone Miner Metab       Date:  2009-03-27       Impact factor: 2.626

Review 10.  High-dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases.

Authors:  Norito Ishii; Takashi Hashimoto; Detlef Zillikens; Ralf J Ludwig
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.